Status and Challenges for Vaccination against Avian H9N2 Influenza Virus in China
- PMID: 36143363
- PMCID: PMC9505450
- DOI: 10.3390/life12091326
Status and Challenges for Vaccination against Avian H9N2 Influenza Virus in China
Abstract
In China, H9N2 avian influenza virus (AIV) has become widely prevalent in poultry, causing huge economic losses after secondary infection with other pathogens. Importantly, H9N2 AIV continuously infects humans, and its six internal genes frequently reassort with other influenza viruses to generate novel influenza viruses that infect humans, threatening public health. Inactivated whole-virus vaccines have been used to control H9N2 AIV in China for more than 20 years, and they can alleviate clinical symptoms after immunization, greatly reducing economic losses. However, H9N2 AIVs can still be isolated from immunized chickens and have recently become the main epidemic subtype. A more effective vaccine prevention strategy might be able to address the current situation. Herein, we analyze the current status and vaccination strategy against H9N2 AIV and summarize the progress in vaccine development to provide insight for better H9N2 prevention and control.
Keywords: H9N2 AIV; antigenicity; influenza virus; vaccine.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- Chen B.L., Zhang Z.J., Chen W.B. Study on avian influenza I. Isolation and preliminary serological identification of avian influenza A virus in chickens. China J. Vet. Med. 1994;10:3–5.
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
